Diabetes
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Kato, H.
Right arrow Articles by Kadowaki, T.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Kato, H.
Right arrow Articles by Kadowaki, T.
Social Bookmarking
 Add to CiteULike   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?
Diabetes 50:113-122, 2001
© 2001 by the American Diabetes Association, Inc.

Mechanism of Amelioration of Insulin Resistance by ß3-Adrenoceptor Agonist AJ-9677 in the KK-Ay/Ta Diabetic Obese Mouse Model

Hiroshi Kato, Mayumi Ohue, Kaori Kato, Akinori Nomura, Kaoru Toyosawa, Yasuji Furutani, Satoshi Kimura, and Takashi Kadowaki

From the Department of Pharmacology III (H.K., M.O., K.K., Y.F.), Discovery Research Laboratories; the Research and Development Coordination (A.N.) and the Department of Toxicology (K.T.), Developmental Research Laboratories, Dainippon Pharmaceutical Co., Osaka; and the Department of Metabolic Diseases (H.K., S.K., T.K.), Graduate School of Medicine, University of Tokyo, Tokyo, Japan.

Address correspondence and reprint requests to Hiroshi Kato, Department of Pharmacology III, Discovery Research Laboratories, Dainippon Pharmaceutical Co., Ltd., Osaka 564-0053, Japan. E-mail: hiroshi-kato{at}dainippon-pharm.co.jp .

The mechanism by which the specific ß3-adrenoceptor agonist AJ-9677 relieves insulin resistance in vivo was investigated by studying its effects in the white and brown adipose tissues of the KK-Ay/Ta diabetic obese mouse model. AJ-9677 reduced the total weight of white adipose tissues by reducing the size of the adipocytes, an effect associated with the normalization of tumor necrosis factor-{alpha} (TNF-{alpha}) and leptin expression levels. The levels of uncoupling protein (UCP)-1 mRNA in brown adipose tissue were increased threefold. AJ-9677 caused a marked increase (20- to 80-fold) in the expression of UCP-1 in white adipose tissues. The levels of UCP-2 mRNA were increased in both the white and brown adipose tissues of diabetic obese mice, and AJ-9677 further upregulated UCP-2 mRNA levels in brown adipose tissue, but reduced its levels in white adipose tissue. UCP-3 mRNA levels were not essentially changed by AJ-9677. However, AJ-9677 significantly (two- to four-fold) upregulated the GLUT4 mRNA and protein levels in white and brown adipose tissues and the gastrocnemius. The generation of small adipocytes, presumably mediated by increased expression of UCP-1 in addition to increased lipolysis in response to AJ-9677, was associated with decreased TNF-{alpha} and free fatty acid production and may be the mechanism of amelioration of insulin resistance in KK-Ay/Ta diabetic obese mice.



Add to CiteULike CiteULike   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
DiabetesHome page
M. Serino, R. Menghini, L. Fiorentino, R. Amoruso, A. Mauriello, D. Lauro, P. Sbraccia, M. L. Hribal, R. Lauro, and M. Federici
Mice Heterozygous for Tumor Necrosis Factor-{alpha} Converting Enzyme Are Protected From Obesity-Induced Insulin Resistance and Diabetes
Diabetes, October 1, 2007; 56(10): 2541 - 2546.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
E. N. Hampton, M. W. Knuth, J. Li, J. L. Harris, S. A. Lesley, and G. Spraggon
The self-inhibited structure of full-length PCSK9 at 1.9 A reveals structural homology with resistin within the C-terminal domain
PNAS, September 11, 2007; 104(37): 14604 - 14609.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
L. M. Redman, L. de Jonge, X. Fang, B. Gamlin, D. Recker, F. L. Greenway, S. R. Smith, and E. Ravussin
Lack of an Effect of a Novel {beta}3-Adrenoceptor Agonist, TAK-677, on Energy Metabolism in Obese Individuals: A Double-Blind, Placebo-Controlled Randomized Study
J. Clin. Endocrinol. Metab., February 1, 2007; 92(2): 527 - 531.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Endocrinol. Metab.Home page
H. Kim, P. A. Pennisi, O. Gavrilova, S. Pack, W. Jou, J. Setser-Portas, J. East-Palmer, Y. Tang, V. C. Manganiello, and D. LeRoith
Effect of adipocyte beta3-adrenergic receptor activation on the type 2 diabetic MKR mice
Am J Physiol Endocrinol Metab, June 1, 2006; 290(6): E1227 - E1236.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Endocrinol. Metab.Home page
J. G. Granneman, P. Li, Z. Zhu, and Y. Lu
Metabolic and cellular plasticity in white adipose tissue I: effects of {beta}3-adrenergic receptor activation
Am J Physiol Endocrinol Metab, October 1, 2005; 289(4): E608 - E616.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Endocrinol. Metab.Home page
P. Li, Z. Zhu, Y. Lu, and J. G. Granneman
Metabolic and cellular plasticity in white adipose tissue II: role of peroxisome proliferator-activated receptor-{alpha}
Am J Physiol Endocrinol Metab, October 1, 2005; 289(4): E617 - E626.
[Abstract] [Full Text] [PDF]


Home page
J EndocrinolHome page
G Uckaya, P Delagrange, A Chavanieu, G Grassy, M-F Berthault, A Ktorza, E Cerasi, G Leibowitz, and N Kaiser
Improvement of metabolic state in an animal model of nutrition-dependent type 2 diabetes following treatment with S 23521, a new glucagon-like peptide 1 (GLP-1) analogue
J. Endocrinol., March 1, 2005; 184(3): 505 - 513.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Regul. Integr. Comp. Physiol.Home page
Y. Hatakeyama, Y. Sakata, S. Takakura, T. Manda, and S. Mutoh
Acute and chronic effects of FR-149175, a {beta}3-adrenergic receptor agonist, on energy expenditure in Zucker fatty rats
Am J Physiol Regulatory Integrative Comp Physiol, August 1, 2004; 287(2): R336 - R341.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Endocrinol. Metab.Home page
J. G. Granneman, M. Burnazi, Z. Zhu, and L. A. Schwamb
White adipose tissue contributes to UCP1-independent thermogenesis
Am J Physiol Endocrinol Metab, December 1, 2003; 285(6): E1230 - E1236.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Diabetes Diabetes Care Clinical Diabetes Diabetes Spectrum
Copyright © 2001 by the American Diabetes Association.